Marco Tullio Rodrigues Alves
Overview
Explore the profile of Marco Tullio Rodrigues Alves including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Athaydes Seabra Ferreira H, Ricardo Aluotto Scalzo Junior S, Kelton Santos de Faria K, Henrique Costa Silva G, Tullio Rodrigues Alves M, Lobo A, et al.
Int J Pharm
. 2024 Sep;
665:124696.
PMID: 39265853
Advances in gene therapy, exemplified by mRNA vaccines against COVID-19, highlight the importance of lipid nanoparticles (LNPs) for nucleic acid delivery despite challenging storage conditions. Substituting mRNA with pDNA in...
2.
da Silva W, Costa P, Ricardo Aluotto Scalzo Junior S, Ferreira H, Dias Moura Prazeres P, Campos C, et al.
Int J Nanomedicine
. 2024 Mar;
19:2655-2673.
PMID: 38500680
Introduction: Immunotherapy has revolutionized cancer treatment by harnessing the immune system to enhance antitumor responses while minimizing off-target effects. Among the promising cancer-specific therapies, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)...
3.
Guimaraes L, Costa P, Ricardo Aluotto Scalzo Junior S, Athaydes Seabra Ferreira H, Braga A, de Oliveira L, et al.
Nat Commun
. 2024 Jan;
15(1):590.
PMID: 38238326
A safe and effective vaccine with long-term protection against SARS-CoV-2 variants of concern (VOCs) is a global health priority. Here, we develop lipid nanoparticles (LNPs) to provide safe and effective...